Online inquiry

IVTScrip™ mRNA-Human ATG3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK25158MR)

This product GTTS-WK25158MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ATG3 protein. This product can be used in Monocyte-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001278712.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 64422
UniProt ID Q9NT62
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ATG3, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK25158MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK3130MR IVTScrip™ mRNA-Human Carboxypeptidase M, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Carboxypeptidase M
GTTS-WK20267MR IVTScrip™ mRNA-Human ANAPC1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANAPC1
GTTS-WK13119MR IVTScrip™ mRNA-Human ADCY1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADCY1
GTTS-WK18438MR IVTScrip™ mRNA-Human ALPI, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ALPI
GTTS-WK11534MR IVTScrip™ mRNA-Human ACOT2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACOT2
GTTS-WK16091MR IVTScrip™ mRNA-Human ANKK1, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKK1
GTTS-WK25718MR IVTScrip™ mRNA-Human ASMTL, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASMTL
GTTS-WK1325MR IVTScrip™ mRNA-Human HMOX1, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA HMOX1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →